Home » News » Harborside Selects Sheridan PubFactory to Host Seminal Oncology Journal

Hanover, PA —Harborside, a leading provider of oncology content, has chosen Sheridan’s PubFactory hosting platform for flagship journal JNCCN—Journal of the National Comprehensive Cancer Network. Harborside will benefit from Sheridan’s end-to-end publication services offering.

JNCCN—Journal of the National Comprehensive Cancer Network, published by Harborside on behalf of the National Comprehensive Cancer Network, will launch on PubFactory in 2019.

“Moving our hosting to PubFactory provides Harborside with three benefits that no other online platform host in the market can: an extension of our valued relationship with our content services provider; the highest quality, high-touch support; and an exciting mechanism for growth in the form of the platform’s SiteGen site launch module,” noted Conor Lynch, Executive Vice President and a Principal at Harborside.

“We are thrilled to increase our partnership with Harborside to include hosting on our PubFactory platform,” said Paul Bozuwa, President of Sheridan, a CJK Group company. “Harborside will take full advantage of the end-to-end production workflow services and technologies that Sheridan offers, introducing both time and cost efficiencies to their publishing programs.”

About Sheridan
Sheridan is a leading provider of print, publishing services, and technology solutions to publishers, associations, university presses, and catalogers. A division of CJK Group, Inc., Sheridan has five U.S.‐based production facilities; each location has a market specialty that supports scholarly journals, books, magazines, reprints, or catalogs. Sheridan is also the provider of the scholarly publishing platform, PubFactory.
www.sheridan.com / www.pubfactory.com

About Harborside
Harborside is a market-leading provider of oncology information to the entire clinical cancer audience. The company offers a comprehensive suite of communication and education platforms, including publications, video production, live conferences, and podcasts. Harborside is the current publisher of JNCCNJournal of the National Comprehensive Cancer Network, The ASCO Post, the Journal of the Advanced Practitioner in Oncology, and Journal of Oncology Practice. Harborside is also the sales and marketing representative for Journal of Clinical Oncology (JCO), Journal of Global Oncology, JCO-Precision Oncology, and JCO-Clinical Cancer Informatics. www.harborsidepress.com